💊Will INS018_055 be FDA-approved by 2030?
3
Ṁ90Ṁ472030
48%
chance
1H
6H
1D
1W
1M
ALL
Insilico Medicine's AI-designed drug for idiopathic pulmonary fibrosis, INS018_055, has entered Phase II clinical trials. Will it become (one of) the first AI-designed drugs to get FDA approval?
This question is managed and resolved by Manifold.
Market context
Get 
1,000 to start trading!
1,000People are also trading
Related questions
Will a vaccine for HIV be approved by the FDA by 2030?
16% chance
Will AOH1996 be FDA approved before 2040?
40% chance
Will a drug to be used by most healthy adults be approved by 2043 year end?
72% chance
Will Xenobots Be Approved By The FDA Before 2030?
32% chance
Will a drug that didn't go through human clinical trials be approved by 2034?
26% chance
The FDA will approve an AI developed cure before the end of the decade (<2030) for a previously incurable major illness.
26% chance
Will it be possible to obtain FDA approval for a drug based on protein folding stimulations without human clinical trials by 2035?
9% chance
Will the FDA publicly accept a multi-condition geroscience endpoint as sufficient to establish efficacy before 2031?
52% chance
How many AI-generated drugs will be approved by the FDA by the end of 2030?
15
Will FDA approve more than 10 new mRNA based vaccines before 2030?
65% chance